Global Mobile Health (mHealth) & mHealth Apps Market (North America-The US; Europe-Germany; Asia Pacific-Japan, China & India) Outlook 2022

June 2018 | 82 pages | ID: G538C42640CEN
Rockville Research

Abstracts

Profound interest in mHealth is increasingly becoming advent worldwide. It has emerged from the convergence of healthcare and mobile technology. It encompasses wide application areas. Off late, rise in popularity of mHealth apps has brought about development of more personalized mHealth apps catering to various healthcare segments. The report “Global Mobile Health (mHealth) & mHealth Apps Market (North America-The US; Europe-Germany; Asia Pacific-Japan, China & India) Outlook 2022” provides an in-depth analysis of the current scenario, detailed market outlook of global mobile health market. Geographical segmentation is done across major markets such as North America (the US), Europe (Germany) and Asia Pacific (Japan, China & India). Market outlook for overall market as well as aforementioned regions has been provided for the period 2017-22.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global mobile health and mobile health apps market. The report has been segmented as following:-

Geographical Coverage

• North America - The US
• Europe – Germany
• Asia Pacific – Japan, China & India

Companies Coverage

• Abbott Laboratories
• Johnson & Johnson
• AstraZeneca plc
• Novartis AG
• Pfizer Inc.

Contents

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. MHEALTH

3.1 Introduction
  3.1.1 Overview
  3.1.2 Business Models
  3.1.3 Application Areas
3.2 Market Analysis
  3.2.1 Market Sizing (Actual & Forecasted)
  3.2.2 Market Share by End-Use
  3.2.3 Market Share by Region

4. MHEALTH APPS

4.1 Introduction
  4.1.1 Overview
  4.1.2 Segmentation
  4.1.3 mHealth Value Chain Analysis

5. MARKET ANALYSIS

5.1 Market Sizing (Actual & Forecasted)
  5.1.1 Market Sizing by Value (Actual & Forecasted)
  5.1.2 Market Sizing by Volume (Actual & Forecasted)
5.2 Market Share Analysis
  5.2.1 Market Share by Type
  5.2.2 Market Share by Platform
  5.2.3 Market Share by End-User
  5.2.5 Market Share by Distribution Channel
  5.2.6 Market Share by Region

6. REGIONAL ANALYSIS

6.1 North America
  6.1.1 Market Sizing (Actual & Forecasted)
  6.1.2 The US
    6.1.2.1 Market Size by Value (Actual & Forecasted)
    6.1.2.2 Market Size by Volume (Actual & Forecasted)
    6.1.2.3 Market Share by Distribution Channel
6.2 Europe
  6.2.1 Market Sizing (Actual & Forecasted)
  6.2.2 Germany
    6.2.2.1 Market Size by Value (Actual & Forecasted)
    6.2.2.2 Market Size by Volume (Actual & Forecasted)
    6.2.2.3 Market Share by App Type
6.3 Asia Pacific
  6.3.1 Market Sizing (Actual & Forecasted)
  6.3.2 Market Share by Nations
  6.3.3 Japan
    6.3.3.1 Market Size by Value (Actual & Forecasted)
    6.3.3.2 Market Size by Volume (Actual & Forecasted)
  6.3.4 China
    6.3.4.1 Market Size by Value (Actual & Forecasted)
    6.3.4.2 Market Size by Volume (Actual & Forecasted)
  6.3.5 India
    6.3.5.1 Market Size by Value (Actual & Forecasted)
    6.3.5.2 Market Size by Volume (Actual & Forecasted)

7. MARKET DYNAMICS

7.1 Industrial Trends & Developments
  7.1.1 Apps for Different Healthcare Segments
  7.1.2 Mergers & Acquisitions
7.2 Growth Drivers
  7.2.1 Higher Adoption of Smartphones
  7.2.2 Growing Internet Penetration
  7.2.3 Better Health Management
  7.2.4 Cost Effective
7.3 Challenges
  7.3.1 Behavioral Barriers
  7.3.2 Reimbursement Issues
  7.3.3 Lack of Standardization and Interoperability
  7.3.4 Security Risks

8. COMPETITIVE LANDSCAPE

9. COMPANY PROFILES

9.1 Abbott Laboratories
9.2 Johnson & Johnson
9.3 Novartis International AG
9.4 AstraZeneca plc
9.5 Pfizer Inc.